Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$41.48 USD
+0.60 (1.47%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $41.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Brokerage Reports
Bristol Myers Squibb Company [BMY]
Reports for Purchase
Showing records 141 - 160 ( 441 total )
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended October 23
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for BMY.
Provider: Stock Traders Daily
Analyst: Research Department